📰 Select Executive News
Select Executive News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Select Executive. Real-time updates on events, politics, business and more.
March 26, 2024
Table of Contents Table of Contents Contents Letter to shareholders ...
February 18, 2024
Amtrak's first-ever points sale is running from now until Feb. 29.
April 9, 2023
Insider's reporter took overnight trips Amtrak's Lake Shore Limited and Empire Builder trains. From the food to the beds, here's how they compare.
April 3, 2023
Amtrak's little-known loyalty program is free to join, and the perks can be pretty lucrative - especially for frequent train travelers.
January 5, 2023
Topic: Immunotherapy Advantages Over Surgical TreatmentCLEVELAND, OH / ACCESSWIRE / January 5, 2023 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company developing novel immunotherapies for brain
November 22, 2022
Topic: Benefits of Immunotherapies Versus Conventional Chemotherapy for Patients and Their Support NetworksCLEVELAND, OH / ACCESSWIRE / November 22, 2022 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical
October 21, 2022
NovAccess Global Announces Fireside Chat with Board Member Perspectives - read this article along with other careers information, tips and advice on BioSpace
October 20, 2022
Topic: Opportunities for the Biomedical Field and for ShareholdersCLEVELAND, OH / ACCESSWIRE / October 20, 2022 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company developing novel immunotherapies
September 29, 2022
29.09.2022 - CLEVELAND, OH / ACCESSWIRE / September 29, 2022 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company developing novel immunotherapies for brain tumor patients, today announced that it will be conducting a series of interviews with its ... Seite 1
September 29, 2022
CLEVELAND, OH / ACCESSWIRE / September 29, 2022 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company developing novel immunotherapies for brain tumor patients, today announced that it will be conducting